PMID- 31699046 OWN - NLM STAT- MEDLINE DCOM- 20200611 LR - 20221207 IS - 1471-2296 (Electronic) IS - 1471-2296 (Linking) VI - 20 IP - 1 DP - 2019 Nov 7 TI - The impact of an intervention to increase uptake to structured self-management education for people with type 2 diabetes mellitus in primary care (the embedding package), compared to usual care, on glycaemic control: study protocol for a mixed methods study incorporating a wait-list cluster randomised controlled trial. PG - 152 LID - 10.1186/s12875-019-1038-0 [doi] LID - 152 AB - BACKGROUND: Approximately 425 million people globally have diabetes, with ~ 90% of these having Type 2 Diabetes Mellitus (T2DM). This is a condition that leads to a poor quality of life and increased risk of serious health complications. Structured self-management education (SSME) has been shown to be effective in improving glycaemic control and patient related outcome measures and to be cost-effective. However, despite the demonstrated benefits, attendance at SSME remains low. An intervention has been developed to embed SSME called the 'Embedding Package'. The intervention aims to address barriers and enhance enablers to uptake of SSME at patient, healthcare professional and organisational levels. It comprises a marketing strategy, user friendly and effective referral pathways, new roles to champion SSME and a toolkit of resources. METHODS: A mixed methods study incorporating a wait-list cluster randomised trial and ethnographic study, including 66 UK general practices, will be conducted with two intervention start times (at 0 and 9 months), each followed by an active delivery phase. At 18 months, the intervention will cease to be actively delivered and a 12 month observational follow-up phase will begin. The intervention, the Embedding Package, aims to increase SSME uptake and subsequent improvements in health outcomes, through a clear marketing strategy, user friendly and effective referral pathways, a local clinical champion and an 'Embedder' and a toolkit of resources for patients, healthcare professionals and other key stakeholders. The primary aim is, through increasing uptake to and attendance at SSME, to reduce HbA1c in people with T2DM compared with usual care. Secondary objectives include: assessing whether there is an increase in referral to and uptake of SSME and improvements in biomedical and psychosocial outcomes; an assessment of the sustainability of the Embedding Package; contextualising the process of implementation, sustainability of change and the 'fit' of the Embedding Package; and an assessment of the cost-effectiveness of the Embedding Package. DISCUSSION: This study will assess the effectiveness, cost-effectiveness and sustainability of the Embedding Package, an intervention which aims to improve biomedical and psychosocial outcomes of people with T2DM, through increased referral to and uptake of SSME. TRIAL REGISTRATION: International Standard Randomised Controlled Trials Number ISRCTN23474120. Assigned 05/04/2018. The study was prospectively registered. On submission of this manuscript practice recruitment is complete, participant recruitment is ongoing and expected to be completed by the end of 2019. FAU - Davies, Melanie J AU - Davies MJ AD - Diabetes Research Centre, University of Leicester, Leicester, UK. AD - Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester, UK. FAU - Kristunas, Caroline A AU - Kristunas CA AD - Diabetes Research Centre, University of Leicester, Leicester, UK. AD - Biostatistics Research Group, Department of Health Sciences, College of Life Sciences, University of Leicester, George Davies Centre , University Road, Leicester, LE1 7RH, UK. FAU - Alshreef, Abualbishr AU - Alshreef A AD - School of Health and Related Research, University of Sheffield, Sheffield, UK. FAU - Dixon, Simon AU - Dixon S AD - School of Health and Related Research, University of Sheffield, Sheffield, UK. FAU - Eborall, Helen AU - Eborall H AD - Biostatistics Research Group, Department of Health Sciences, College of Life Sciences, University of Leicester, George Davies Centre , University Road, Leicester, LE1 7RH, UK. FAU - Glab, Agnieszka AU - Glab A AD - Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester, UK. FAU - Huddlestone, Lisa AU - Huddlestone L AD - Biostatistics Research Group, Department of Health Sciences, College of Life Sciences, University of Leicester, George Davies Centre , University Road, Leicester, LE1 7RH, UK. FAU - Hudson, Nicky AU - Hudson N AD - Centre for Reproduction Research, School of Applied Social Science, De Montfort University, Leicester, UK. FAU - Khunti, Kamlesh AU - Khunti K AD - Diabetes Research Centre, University of Leicester, Leicester, UK. AD - Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester, UK. FAU - Martin, Graham AU - Martin G AD - THIS Institute, University of Cambridge, Cambridge, UK. FAU - Northern, Alison AU - Northern A AD - Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester, UK. FAU - Patterson, Mike AU - Patterson M AD - Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester, UK. FAU - Pritchard, Rebecca AU - Pritchard R AD - Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester, UK. FAU - Schreder, Sally AU - Schreder S AD - Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester, UK. FAU - Stribling, Bernie AU - Stribling B AD - Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester, UK. FAU - Turner, Jessica AU - Turner J AD - Centre for Reproduction Research, School of Applied Social Science, De Montfort University, Leicester, UK. FAU - Gray, Laura J AU - Gray LJ AUID- ORCID: 0000-0002-9284-9321 AD - Biostatistics Research Group, Department of Health Sciences, College of Life Sciences, University of Leicester, George Davies Centre , University Road, Leicester, LE1 7RH, UK. Lg48@le.ac.uk. LA - eng SI - ISRCTN/ISRCTN23474120 GR - RP-PG-1212-20004/DH_/Department of Health/United Kingdom PT - Comparative Study PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20191107 PL - England TA - BMC Fam Pract JT - BMC family practice JID - 100967792 RN - 0 (Glycated Hemoglobin A) RN - 0 (hemoglobin A1c protein, human) SB - IM MH - Adult MH - Anthropology, Cultural MH - Cost-Benefit Analysis MH - Diabetes Mellitus, Type 2/economics/*therapy MH - Female MH - Glycated Hemoglobin/analysis MH - Humans MH - Interviews as Topic MH - Male MH - Patient Education as Topic/*methods MH - Primary Health Care/economics/*methods MH - Self-Management/economics/*methods PMC - PMC6839094 OTO - NOTNLM OT - Cluster randomised trial OT - Diabetes education OT - Diabetes self-management OT - Randomised controlled trial OT - Self-management OT - Structured education OT - Type 2 diabetes OT - Wait-list COIS- Conflicts of interest: We do not hold any conflicts of interest, however, for transparency we provide the following statement of conflict: MJD is the Principal Investigator (PI) on the DESMOND programme (Diabetes education and self-management for people with newly diagnosed Type 2 diabetes). BS, SS and AN are employed by the University Hospitals of Leicester NHS Trust, which receives not-for-profit income for DESMOND. MJD, KK, HE, LG, AN, SS and BS are actively engaged in research and have previously received grants for DESMOND from NIHR, MRC and Diabetes UK to develop and test Diabetes Self-Management Education and Support programmes like DESMOND. The University Hospitals of Leicester (UHL) NHS Trust (for which BS, SS and AN have a contract) receives licensing fees to support implementation of the DESMOND programme in CCGs in the UK, Ireland and Australia. All other authors have no competing interests. EDAT- 2019/11/09 06:00 MHDA- 2020/06/12 06:00 PMCR- 2019/11/07 CRDT- 2019/11/09 06:00 PHST- 2019/10/04 00:00 [received] PHST- 2019/10/17 00:00 [accepted] PHST- 2019/11/09 06:00 [entrez] PHST- 2019/11/09 06:00 [pubmed] PHST- 2020/06/12 06:00 [medline] PHST- 2019/11/07 00:00 [pmc-release] AID - 10.1186/s12875-019-1038-0 [pii] AID - 1038 [pii] AID - 10.1186/s12875-019-1038-0 [doi] PST - epublish SO - BMC Fam Pract. 2019 Nov 7;20(1):152. doi: 10.1186/s12875-019-1038-0.